Effects of a tailored dose of varenicline on post-quitting urges to smoke

Mise à jour : Il y a 5 ans
Référence : EUCTR2010-022335-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The principle question this project plans to answer is to determine if a tailored dose of varenicline provides better withdrawal and craving relief in the first week of abstinence than a standard varenicline dose. The primary outcome measure will be the rating of urges to smoke one week after the target quit date assessed by Mood and Physical Symptoms Scale [MPSS] (West and Hajek 2004).


Critère d'inclusion

  • Tobacco dependence (smoking cessation)

Liens